Phase II trial of fenretinide (NSC 374551) in patients with recurrent small cell lung cancer.
Schneider BJ, Worden FP, Gadgeel SM, Parchment RE, Hodges CM, Zwiebel J, Dunn RL, Wozniak AJ, Kraut MJ, Kalemkerian GP.
Schneider BJ, et al. Among authors: kraut mj.
Invest New Drugs. 2009 Dec;27(6):571-8. doi: 10.1007/s10637-009-9228-6. Epub 2009 Feb 19.
Invest New Drugs. 2009.
PMID: 19225720
Clinical Trial.